Allen's son, Wesley, was diagnosed with acute promyelocytic leukemia in January 2025. Hines-Allen missed a game d ...

Jaguars defensive end Josh Hines-Allen said his seven-year-old son, Wesley, is in remission after fighting acute ...

Jacksonville Jaguars DE Josh Hines-Allen disclosed his son's pediatric cancer diagnosis and the his campaign for ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Jacksonville Jaguars DE Josh Hines-Allen gave insight to how he and his family handled his son's cancer diagnosis.

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies ...

Researchers discovered that an A216V mutation in the unrearranged PML allele confers resistance to arsenic trioxide in acute promyelocytic leukemia, revealing a hidden cause of relapse and ...

But, I think now, I would say yes ... it should be the new standard of care." APL is a rare and distinct subtype of acute myeloid leukemia, with fewer than 1,000 cases diagnosed in the U.S. each year.

Purpose: To analyze patient cases of therapy-related acute promyelocytic leukemia (tAPL), occurring after chemotherapy (CT), radiotherapy (RT) or both for a prior disorder, diagnosed during the last ...